Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The mitotic surveillance pathway requires PLK1-dependent 53BP1 displacement from kinetochores

View through CrossRef
Abstract 53BP1 acts at the crossroads between DNA repair and p53-mediated stress response. With its interactor USP28, it is part of the mitotic surveillance pathway (MSP), a sensor that monitors the duration of cell division, promoting p53-dependent cell cycle arrest when a critical time threshold is surpassed. 53BP1 dynamically associates with kinetochores, being recruited during prophase, and then undergoing a time-dependent loss of affinity. However, the relevance of this behaviour remains unclear. Here, we identify CENP-F as an interaction partner and kinetochore receptor for 53BP1. By engineering human cells with a CENP-F point mutation, we demonstrate that preventing 53BP1 kinetochore localization does not reduce MSP proficiency. Strikingly, however, preventing the loss of 53BP1 from the kinetochore by inhibiting Polo-like kinase 1 (PLK1) restrains MSP activity, a phenomenon that is abrogated in the CENP-F mutant condition. Taken together, we demonstrate that kinetochore-loaded 53BP1 represents an MSP functionally inhibited state and that PLK1-dependent re-localization of 53BP1 represents an important layer of MSP regulation.
Title: The mitotic surveillance pathway requires PLK1-dependent 53BP1 displacement from kinetochores
Description:
Abstract 53BP1 acts at the crossroads between DNA repair and p53-mediated stress response.
With its interactor USP28, it is part of the mitotic surveillance pathway (MSP), a sensor that monitors the duration of cell division, promoting p53-dependent cell cycle arrest when a critical time threshold is surpassed.
53BP1 dynamically associates with kinetochores, being recruited during prophase, and then undergoing a time-dependent loss of affinity.
However, the relevance of this behaviour remains unclear.
Here, we identify CENP-F as an interaction partner and kinetochore receptor for 53BP1.
By engineering human cells with a CENP-F point mutation, we demonstrate that preventing 53BP1 kinetochore localization does not reduce MSP proficiency.
Strikingly, however, preventing the loss of 53BP1 from the kinetochore by inhibiting Polo-like kinase 1 (PLK1) restrains MSP activity, a phenomenon that is abrogated in the CENP-F mutant condition.
Taken together, we demonstrate that kinetochore-loaded 53BP1 represents an MSP functionally inhibited state and that PLK1-dependent re-localization of 53BP1 represents an important layer of MSP regulation.

Related Results

PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability
PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability
Abstract 53BP1 acts at the crossroads between DNA repair and p53‐mediated stress response. With its interactors p53 and USP28, it is part of the mitotic surveilla...
UBAP2L-dependent coupling of PLK1 localization and stability during mitosis
UBAP2L-dependent coupling of PLK1 localization and stability during mitosis
Abstract PLK1 is an important regulator of mitosis whose protein levels and activity fluctuate during the cell cycle. PLK1 dynamically localizes to various mitotic ...
Abstract 1720: 53BP1 regulates heterochromatin through liquid-liquid phase separation (LLPS)
Abstract 1720: 53BP1 regulates heterochromatin through liquid-liquid phase separation (LLPS)
Abstract As compacted DNA, heterochromatin represses abnormal gene expression by inhibiting DNA transcription and maintains genome integrity by protecting aberrant c...
Abstract 1133: Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state
Abstract 1133: Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state
Abstract One outcome of activation of the PI3K pathway is increased aerobic glycolysis, but the upstream signaling events that regulate the PI3K pathway, thus the Wa...
Abstract 3459: Dual targeting of BTK and PLK1 causes lethal synergistic effects in mantle cell lymphoma
Abstract 3459: Dual targeting of BTK and PLK1 causes lethal synergistic effects in mantle cell lymphoma
Abstract Mantle cell lymphoma (MCL) is an incurable, aggressive B cell malignancy. Ibrutinib, an oral irreversible Bruton's tyrosine (BTK) inhibitor, was FDA-approve...

Back to Top